Top Markets
Coin of the day
Cyfuse Biomedical K.K. Cyfuse Biomedical K.K.

Cyfuse Biomedical K.K.

4892
Rank in Stocks #26819
Established in 2010 and headquartered in Tokyo, Japan, Cyfuse Biomedical K.K.... Established in 2010 and headquartered in Tokyo, Japan, Cyfuse Biomedical K.K. focuses on the creation, production, and distribution of regenerative medicine solutions. The company is actively involved in developing cell-based products for therapeutic regeneration, and it also undertakes contract work for cellular product research and development. Furthermore, Cyfuse Biomedical offers advanced Bio 3D Printers, which are instrumental in regenerating a variety of tissues and organs, including cartilage, bones, blood vessels, and nerves. Their specialized equipment includes 'regenova,' a bio 3D printer enabling three-dimensional cell stacking, and 'S-PIKE,' designed for forming complex 3D structures from cells.
Share Price
$3.72
Market Cap
$37.53M
Change (1 day)
4.78%
Change (1 year)
-18.34%
Country
JP
Trade Cyfuse Biomedical K.K. (4892)

Category

P/B ratio for Cyfuse Biomedical K.K. (4892)
P/B ratio as of 2026 TTM: 0
According to Cyfuse Biomedical K.K. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Cyfuse Biomedical K.K. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
6.3419 -
US
3.7087 -
US
6.2413 -
NL
2.5054 -
AU
- -
CH